| Literature DB >> 28675423 |
Guoxiang Xie1,2, Shouli Wang1, Hua Zhang3,4, Aihua Zhao1, Jiajian Liu1, Yueming Ma5, Ke Lan6, Yan Ni2, Changxiao Liu7, Ping Liu3,4, Tianlu Chen1, Wei Jia1,2.
Abstract
The advent of mass spectrometry-based analytical technologies coupled with multivariate statistical methods offer tremendous new opportunities for understanding the pharmacokinetics (PKs) of multicomponent herbal medicines (HMs). We recently proposed a poly-PK strategy to characterize the concentration-time profile and the metabolic response profile of multicomponent HMs using an integrated phytochemical and metabolomics approach. Here, we provided the first example of the poly-PK strategy, in which we simultaneously characterized the PK as well as the metabolic response profiles of a Chinese HM, Huangqi decoction (HQD, consisting of Radix Astragali and Radix Glycyrrhizae), in healthy Chinese volunteers. Using the poly-PK approach, we identified 56 HQD-derived compounds and 292 biotransformed HQD metabolites in human plasma. Additionally, we acquired the concentration-time profiles of these plasma HQD metabolites and correlated them with a plasma metabolomics profile consisting of 166 human endogenous metabolites that were significantly altered in response to HQD intervention.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28675423 DOI: 10.1002/cpt.784
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN: 0009-9236 Impact factor: 6.875